Ehave, Inc. Engages Legal Counsel for Dual Listing of its Common Stock on the Canadian Securities Exchange (CSE)

NEXT STORY
Precipio Adds Another HemeScreen™ Customer
PREV STORY
Press Release Oncology Venture calls first investment tranche of SEK 10 million under its share subscription agreement with Global Corporate Finance
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Genocea Announces Poster Presentation at The European Society for Medical Oncology (ESMO) Congress 2019 in Barcelona and Presentation at an Upcoming Investor Conference

author_avatar
NASDAQ Market News

iCAD Launches Revolutionary Short-term Personalized Risk Assessment Solution for 3D Mammography

author_avatar
NASDAQ Market News

Fate Therapeutics Reports First Quarter 2016 Financial Results

Phase 1/2 Clinical Trial of ProTmune™ for Prevention of Acute GvHD and CMV Infection ...

author_avatar
NASDAQ Market News